Quality of life, long-term survivors and long-term outcome from the ABC-02 study

BACKGROUND: The ABC-02 (Advanced Biliary Tract Cancer) study established cisplatin and gemcitabine (CisGem) as the standard first-line chemotherapy for patients with locally advanced or metastatic biliary tract cancer (BTC). We examine quality of life (QoL), describe the long-term survivors and prov...

Descripción completa

Detalles Bibliográficos
Autores principales: Bridgewater, John, Lopes, Andre, Palmer, Daniel, Cunningham, David, Anthoney, Alan, Maraveyas, Anthony, Madhusudan, Srinivasan, Iveson, Tim, Valle, Juan, Wasan, Harpreet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984909/
https://www.ncbi.nlm.nih.gov/pubmed/27115567
http://dx.doi.org/10.1038/bjc.2016.64

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984909/
https://www.ncbi.nlm.nih.gov/pubmed/27115567
http://dx.doi.org/10.1038/bjc.2016.64

Ejemplares similares